746 related articles for article (PubMed ID: 9499087)
41. HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.
Mangeat B; Gers-Huber G; Lehmann M; Zufferey M; Luban J; Piguet V
PLoS Pathog; 2009 Sep; 5(9):e1000574. PubMed ID: 19730691
[TBL] [Abstract][Full Text] [Related]
42. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments.
Schubert U; Strebel K
J Virol; 1994 Apr; 68(4):2260-71. PubMed ID: 8139011
[TBL] [Abstract][Full Text] [Related]
43. Early degradation of paternal mitochondria in domestic pig (Sus scrofa) is prevented by selective proteasomal inhibitors lactacystin and MG132.
Sutovsky P; McCauley TC; Sutovsky M; Day BN
Biol Reprod; 2003 May; 68(5):1793-800. PubMed ID: 12606393
[TBL] [Abstract][Full Text] [Related]
44. The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors.
Akari H; Bour S; Kao S; Adachi A; Strebel K
J Exp Med; 2001 Nov; 194(9):1299-311. PubMed ID: 11696595
[TBL] [Abstract][Full Text] [Related]
45. Putative alpha-helical structures in the human immunodeficiency virus type 1 Vpu protein and CD4 are involved in binding and degradation of the CD4 molecule.
Tiganos E; Yao XJ; Friborg J; Daniel N; Cohen EA
J Virol; 1997 Jun; 71(6):4452-60. PubMed ID: 9151836
[TBL] [Abstract][Full Text] [Related]
46. The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules.
Kerkau T; Bacik I; Bennink JR; Yewdell JW; Húnig T; Schimpl A; Schubert U
J Exp Med; 1997 Apr; 185(7):1295-305. PubMed ID: 9104816
[TBL] [Abstract][Full Text] [Related]
47. Removal and degradation of the free MHC class II beta chain in the endoplasmic reticulum requires proteasomes and is accelerated by BFA.
Dusseljee S; Wubbolts R; Verwoerd D; Tulp A; Janssen H; Calafat J; Neefjes J
J Cell Sci; 1998 Aug; 111 ( Pt 15)():2217-26. PubMed ID: 9664043
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
49. Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: a predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity.
Yao XJ; Friborg J; Checroune F; Gratton S; Boisvert F; Sékaly RP; Cohen EA
Virology; 1995 Jun; 209(2):615-23. PubMed ID: 7778293
[TBL] [Abstract][Full Text] [Related]
50. Degradation of unassembled soluble Ig subunits by cytosolic proteasomes: evidence that retrotranslocation and degradation are coupled events.
Mancini R; Fagioli C; Fra AM; Maggioni C; Sitia R
FASEB J; 2000 Apr; 14(5):769-78. PubMed ID: 10744633
[TBL] [Abstract][Full Text] [Related]
51. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein.
Verdier F; Chrétien S; Muller O; Varlet P; Yoshimura A; Gisselbrecht S; Lacombe C; Mayeux P
J Biol Chem; 1998 Oct; 273(43):28185-90. PubMed ID: 9774439
[TBL] [Abstract][Full Text] [Related]
52. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
[TBL] [Abstract][Full Text] [Related]
53. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes.
Willey RL; Maldarelli F; Martin MA; Strebel K
J Virol; 1992 Jan; 66(1):226-34. PubMed ID: 1727486
[TBL] [Abstract][Full Text] [Related]
54. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex.
Hu Z; Zhang Z; Doo E; Coux O; Goldberg AL; Liang TJ
J Virol; 1999 Sep; 73(9):7231-40. PubMed ID: 10438810
[TBL] [Abstract][Full Text] [Related]
55. Proteasome and thiol involvement in quality control of glycosylphosphatidylinositol anchor addition.
Wilbourn B; Nesbeth DN; Wainwright LJ; Field MC
Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):111-8. PubMed ID: 9576858
[TBL] [Abstract][Full Text] [Related]
56. Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein.
Tiganos E; Friborg J; Allain B; Daniel NG; Yao XJ; Cohen EA
Virology; 1998 Nov; 251(1):96-107. PubMed ID: 9813206
[TBL] [Abstract][Full Text] [Related]
57. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.
Han Y; Weinman S; Boldogh I; Walker RK; Brasier AR
J Biol Chem; 1999 Jan; 274(2):787-94. PubMed ID: 9873017
[TBL] [Abstract][Full Text] [Related]
58. Degradation of subunits of the Sec61p complex, an integral component of the ER membrane, by the ubiquitin-proteasome pathway.
Biederer T; Volkwein C; Sommer T
EMBO J; 1996 May; 15(9):2069-76. PubMed ID: 8641272
[TBL] [Abstract][Full Text] [Related]
59. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
[TBL] [Abstract][Full Text] [Related]
60. Stimulation of heterologous protein degradation by the Vpu protein of HIV-1 requires the transmembrane and cytoplasmic domains of CD4.
Buonocore L; Turi TG; Crise B; Rose JK
Virology; 1994 Oct; 204(1):482-6. PubMed ID: 8091684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
